Pharmaceutical Gelatin Market - By Product (Type A, Type B), Source (Porcine, Bovine, Fish, Poultry), Function (Stabilizers, Thickeners, Gelling Agents, Film Forming), Application (Capsules, Tablets, Absorbable hemostats), Global Forecast 2023-2032

Pharmaceutical Gelatin Market - By Product (Type A, Type B), Source (Porcine, Bovine, Fish, Poultry), Function (Stabilizers, Thickeners, Gelling Agents, Film Forming), Application (Capsules, Tablets, Absorbable hemostats), Global Forecast 2023-2032

Global Pharmaceutical Gelatin Market will record a significant growth rate from 2023 to 2032. The expanding elderly population and rising health concerns drive the demand for gelatin-based soft gel capsules as a preferred dosage form. According to the United Nations Digital Library, around the world, there were an estimated 727 million people aged 65 or older in 2020. By 2050, this figure is anticipated to more than double, reaching over 1.5 billion people. The percentage of aging people in the world's population is predicted to rise from 9.3% in 2020 to 16% in 2050. One in six persons worldwide will be 65 years of age or older by the middle of the century.

The increasing pharmaceutical and nutraceutical industries' demand for encapsulation and controlled-release systems fuels the use of gelatin capsules. Gelatin's versatility in drug delivery systems, including microencapsulation and sustained-release formulations, propels its adoption. Additionally, stringent quality standards, pharmaceutical innovations, and the global growth of pharmaceutical production contribute to the Pharmaceutical Gelatin Market's continuous expansion.

The overall Pharmaceutical Gelatin Market is classified based on product, source, function, and region.

Based on the product, the type A segment size will register noticeable expansion throughout 2023-2032. Type A gelatin is derived from the acid hydrolysis of collagen and finds extensive use in pharmaceutical and nutraceutical applications due to its excellent gelling and binding properties. It's commonly used in the production of capsules, tablets, and other oral dosage forms. The high demand for Type A gelatin underscores its significance in drug delivery systems and formulation development, making it a vital component of the pharmaceutical gelatin market.

By source, the pharmaceutical gelatin market share from the fish segment will expand noticeably from 2023 to 2032. Fish gelatin obtained from fish skin and bones offers an alternative to mammalian gelatin sources. Its appeal lies in its compatibility with diverse religious and dietary requirements, making it suitable for a broader consumer base. As consumer preferences shift toward non-mammalian sources, the demand for fish gelatin in pharmaceutical applications, such as capsules and coatings, continues to grow, driving its prominence.

Regarding the function, the film-forming segment of the fish gelatin industry will contribute significantly to the market revenue over 2023-2032. Gelatin's ability to create flexible and biocompatible films makes it a preferred choice for coating tablets, capsules, and other pharmaceutical products. These film coatings serve various purposes, including taste masking, controlled release, and protection of active ingredients. As pharmaceutical companies strive for innovative dosage forms and improved patient experiences, the demand for gelatin's film-forming capabilities remains high.

Regionally, the Europe pharmaceutical gelatin market will record an appreciable valuation by 2032 due to the region's robust pharmaceutical and nutraceutical industries and the need for high-quality gelatin for capsule and tablet formulations. Stringent regulatory requirements for safe and effective drug delivery systems encourage the use of gelatin in pharmaceutical applications. Additionally, the growing emphasis on sustainable sourcing and manufacturing processes aligns with gelatin's natural origin, further boosting its demand in the European pharmaceutical gelatin market.